发明名称 AZACYCLOALKYL-SUBSTITUTED ACETIC ACID DERIVATIVE FOR USE AS MMP INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide a method for inhibiting matrix degrading metalloproteinase and provide a preventive treatment for the matrix metalloproteinase dependent conditions in mammals. SOLUTION: The compounds of formula (I) (wherein R represents OH or NHOH; R<SB>1</SB>represents hydrogen, optionally substituted lower alkyl, aryl-lower alkyl, or the like; R<SB>2</SB>represents biarylsulfonyl, or the like; R<SB>3</SB>represents hydrogen, optionally substituted lower alkyl, or the like; R<SB>4</SB>and R<SB>5</SB>each represents hydrogen, lower alkyl, lower alkoxycarbonyl, or the like; m is 0, 1, 2, or 3); pharmaceutically acceptable prodrug derivatives thereof; phamaceutically acceptable salts thereof; and use of phamaceutical compositions comprising its salt are provided. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009137997(A) 申请公布日期 2009.06.25
申请号 JP20090014415 申请日期 2009.01.26
申请人 NOVARTIS AG 发明人 FUJIMOTO ROGER AKI;MCQUIRE LESLIE WIGHTON;MONOVICH LAUREN G;NANTERMET PHILIPPE;PARKER DAVID THOMAS;ROBINSON LESLIE ANN;SKILES JERRY W;TOMMASI RUBEN ALBERTO
分类号 C07D211/34;C12N9/99;A61K31/40;A61K31/445;A61K31/4525;A61K31/4535;A61K31/454;A61K31/4545;A61K31/4725;A61K31/496;A61K31/501;A61K31/5377;A61K31/55;A61P1/02;A61P1/04;A61P7/00;A61P9/00;A61P9/08;A61P9/10;A61P11/00;A61P11/06;A61P17/00;A61P17/02;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P25/02;A61P25/14;A61P27/02;A61P27/06;A61P29/00;A61P31/04;A61P35/00;A61P35/04;A61P43/00;C07D211/32;C07D401/12;C07D405/12;C07D405/14;C07D409/12;C07D409/14;C07D413/14;C07D417/04;C07D417/12;C07D417/14 主分类号 C07D211/34
代理机构 代理人
主权项
地址